Ghada A. Abdelwahab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ghada A. Abdelwahab has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed A. Ismail
Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
2 shared publications Ahmed A. Fadda
1 shared publication- Ahmed Ali Fadda
Department of Chemistry Faculty of Science, Mansoura University Mansoura Egypt
1 shared publication - M. Yasser Alsedfy
Electronics and Nano Devices Lab, Faculty of Science, South Valley University, Qena, Egypt
1 shared publication - Miral A. Abdelmoaz
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University, Kantra, Egypt
1 shared publication - Mohamed Ramadan Elmorsy
Department of Chemistry, Faculty of Science Mansoura University Mansoura Egypt
1 shared publication
Latest Publications
- 1 August 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (8) , 1997-2007
Unveiling the Antitubercular Potential of Furan–Nitrophenyl Schiff Base Hybrids: A Molecular Docking and Drug-Likeness Perspective
In this study, we report the synthesis and characterization using various spectroscopic techniques of a series of six new furan-based Schiff base derivatives as potential antitubercular agents. The strategic incorporation of the furan scaffold and nitro group, both known for their diverse biological activities, provided a strong rationale for their evaluation against tuberculosis. Molecular docking simulations were employed to assess the binding affinities of these compounds towards enoyl-acyl carrier protein reductase (InhA), a validated and essential target in M. tuberculosis. Remarkably, all synthesized compounds exhibited superior binding scores (–6.074 to –9.939 kcal/mol), compared to the clinically used antitubercular drug isoniazid (–4.585 kcal/mol), indicating their potential as potent InhA inhibitors. Furthermore, in silico absorption, distribution, metabolism, and excretion (ADME) predictions were performed to evaluate the drug-likeness of these compounds. The findings highlight the balanced combination of potent target binding and drug-like characteristics achieved by these furan-based Schiff base hybrids.
- 1 August 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (8) , 1997-2007
Unveiling the Antitubercular Potential of Furan–Nitrophenyl Schiff Base Hybrids: A Molecular Docking and Drug-Likeness Perspective
In this study, we report the synthesis and characterization using various spectroscopic techniques of a series of six new furan-based Schiff base derivatives as potential antitubercular agents. The strategic incorporation of the furan scaffold and nitro group, both known for their diverse biological activities, provided a strong rationale for their evaluation against tuberculosis. Molecular docking simulations were employed to assess the binding affinities of these compounds towards enoyl-acyl carrier protein reductase (InhA), a validated and essential target in M. tuberculosis. Remarkably, all synthesized compounds exhibited superior binding scores (–6.074 to –9.939 kcal/mol), compared to the clinically used antitubercular drug isoniazid (–4.585 kcal/mol), indicating their potential as potent InhA inhibitors. Furthermore, in silico absorption, distribution, metabolism, and excretion (ADME) predictions were performed to evaluate the drug-likeness of these compounds. The findings highlight the balanced combination of potent target binding and drug-like characteristics achieved by these furan-based Schiff base hybrids.